chartexchange

RARE
Ultragenyx Pharmaceutical Inc.
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
17.73USD+6.168%(+1.03)5,164,234
Pre-marketNov 18, 2026 8:01:30 AM EST
16.75USD+0.299%(+0.05)
After-hoursNov 18, 2026 4:32:30 PM EST
17.82USD+0.508%(+0.09)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Emil Kakkis
HQ
Novato, CA, USA
Previous Close
$16.70
Beta
1.38
52-Week High
$39.89 2025-12-08
52-Week Low
$12.73 2026-09-16
SMA 50
$15.41
SMA 200
$22.41
Avg. Vol 10D
4.16M
Avg. Vol 30D
3.74M
Avg. Vol 90D
3.89M
Relative Vol
1.38
101.92M
93.25M
23,624,682
0.4100%
3,500,000
218
RARE Profile

ultragenyx is a clinical-stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases. founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies. our company is led by an experienced management team in rare disease therapeutics. recognizing that our primary responsibility is to our patients, we are working with advocacy groups to provide support and outreach to individuals and families affected by these disorders and engage them in the clinical testing process. we are also working with regulatory agencies to design and conduct high quality clinical studies that meet the requirements for approval. we are creating an improved model for successful rare disease d

RARE Performance
PeriodPriceDateChangeBeta
1W16.272026-11-12+8.97%2.135
1M15.072026-10-19+17.65%2.034
3M26.242026-08-19-32.43%1.128
6M22.452026-05-19-21.02%1.091
1Y31.862025-11-19-44.35%1.383
2Y45.132024-11-19-60.71%—
5Y79.322021-11-19-77.65%1.081
RARE Stock Summary

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) stock price today is $17.73, and today's volume is 5,164,234. RARE is up 6.168% today. The 30 day average volume is 3.74M. RARE market cap is $1.81B with 101.92M shares outstanding.